newsfilter
← Latest News
GlobeNewswire·

Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights

Positive topline data from Part B of the TX45 Phase 1b trial demonstrated improvements in both left heart function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced